Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Kancera AB (publ) (3EE0.F)

Compare
0.0920
-0.0079
(-7.91%)
As of 9:16:31 AM GMT+2. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
14
14
1,035
753
1,704
Gross Profit
--
--
1,035
753
1,704
Operating Expense
46,175
46,175
66,077
52,687
46,960
Operating Income
-46,161
-46,161
-65,042
-51,934
-45,256
Net Non Operating Interest Income Expense
1,595
1,595
153
-50
-17
Pretax Income
-44,566
-44,566
-64,889
-52,484
-45,686
Net Income Common Stockholders
-44,566
-44,566
-64,889
-52,484
-45,686
Diluted NI Available to Com Stockholders
-44,566
-44,566
-64,889
-52,484
-45,686
Basic EPS
-0.39
--
-0.81
-0.88
-0.80
Diluted EPS
-0.39
--
-0.81
-0.88
-0.80
Basic Average Shares
115,332
--
79,620
59,533.2410
57,292.3290
Diluted Average Shares
115,332
--
79,620
59,533.2410
57,292.3290
Total Operating Income as Reported
-46,161
-46,161
-65,042
-51,934
-45,256
Total Expenses
46,175
46,175
66,077
52,687
46,960
Net Income from Continuing & Discontinued Operation
-44,566
-44,566
-64,889
-52,484
-45,686
Normalized Income
-44,566
-44,566
-64,889
-52,484
-45,686
Interest Income
--
--
283
68
--
Interest Expense
--
--
--
118
17
Net Interest Income
1,595
1,595
153
-50
-17
EBIT
-46,161
-46,161
-65,042
-52,366
-45,669
EBITDA
-46,161
-46,161
-62,042
-52,006
-45,349
Reconciled Depreciation
--
--
3,000
360
320
Net Income from Continuing Operation Net Minority Interest
-44,566
-44,566
-64,889
-52,484
-45,686
Normalized EBITDA
-46,161
-46,161
-62,042
-52,006
-45,349
12/31/2021 - 3/14/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6DW.F D. Western Therapeutics Institute, Inc.
0.5550
-5.93%
 
0T20.F Traws Pharma, Inc.
0.0000
-100.00%
 
BTTAY Biotest Aktiengesellschaft
24.23
+6.27%
 
1HB0.F Scorpius Holdings, Inc.
0.0000
-100.00%
 
B1Q.F NRX Pharmaceuticals Inc. R
1.6600
-5.14%
 
APH0.F Ampio Pharmaceuticals, Inc.
3.6200
0.00%
 
2KZ0.F Kezar Life Sciences, Inc.
3.5600
-11.00%
 
6JU0.F BioCardia, Inc.
0.0000
-100.00%
 
2I9.F Karolinska Development AB (publ)
0.0626
-14.25%
 
2DE0.F Genprex, Inc.
0.0000
-100.00%